Cargando…

Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh

Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastren, Tara, Radchenko, Valery, Hopkins, Philip D., Engle, Jonathan W., Weidner, John W., Copping, Roy, Brugh, Mark, Nortier, F. Meiring, Birnbaum, Eva R., John, Kevin D., Fassbender, Michael Ernst-Heinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741265/
https://www.ncbi.nlm.nih.gov/pubmed/29272318
http://dx.doi.org/10.1371/journal.pone.0190308
_version_ 1783288171762548736
author Mastren, Tara
Radchenko, Valery
Hopkins, Philip D.
Engle, Jonathan W.
Weidner, John W.
Copping, Roy
Brugh, Mark
Nortier, F. Meiring
Birnbaum, Eva R.
John, Kevin D.
Fassbender, Michael Ernst-Heinrich
author_facet Mastren, Tara
Radchenko, Valery
Hopkins, Philip D.
Engle, Jonathan W.
Weidner, John W.
Copping, Roy
Brugh, Mark
Nortier, F. Meiring
Birnbaum, Eva R.
John, Kevin D.
Fassbender, Michael Ernst-Heinrich
author_sort Mastren, Tara
collection PubMed
description Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to isolate (103)Ru in high yield and purity from a proton irradiated thorium matrix on an analytical scale is described herein. The first part employed an anion exchange column to remove cationic actinide/lanthanide impurities along with the majority of the transition metal fission products. Secondly, an extraction chromatographic column utilizing diglycolamide functional groups was used to decontaminate (103)Ru from the remaining impurities. This method resulted in a final radiochemical yield of 83 ± 5% of (103)Ru with a purity of 99.9%. Additionally, measured nuclear reaction cross sections for the formation of (103)Ru and (106)Ru via the (232)Th(p,f)(103,106)Ru reactions are reported within.
format Online
Article
Text
id pubmed-5741265
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57412652018-01-09 Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh Mastren, Tara Radchenko, Valery Hopkins, Philip D. Engle, Jonathan W. Weidner, John W. Copping, Roy Brugh, Mark Nortier, F. Meiring Birnbaum, Eva R. John, Kevin D. Fassbender, Michael Ernst-Heinrich PLoS One Research Article Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to isolate (103)Ru in high yield and purity from a proton irradiated thorium matrix on an analytical scale is described herein. The first part employed an anion exchange column to remove cationic actinide/lanthanide impurities along with the majority of the transition metal fission products. Secondly, an extraction chromatographic column utilizing diglycolamide functional groups was used to decontaminate (103)Ru from the remaining impurities. This method resulted in a final radiochemical yield of 83 ± 5% of (103)Ru with a purity of 99.9%. Additionally, measured nuclear reaction cross sections for the formation of (103)Ru and (106)Ru via the (232)Th(p,f)(103,106)Ru reactions are reported within. Public Library of Science 2017-12-22 /pmc/articles/PMC5741265/ /pubmed/29272318 http://dx.doi.org/10.1371/journal.pone.0190308 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Mastren, Tara
Radchenko, Valery
Hopkins, Philip D.
Engle, Jonathan W.
Weidner, John W.
Copping, Roy
Brugh, Mark
Nortier, F. Meiring
Birnbaum, Eva R.
John, Kevin D.
Fassbender, Michael Ernst-Heinrich
Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title_full Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title_fullStr Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title_full_unstemmed Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title_short Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
title_sort separation of (103)ru from a proton irradiated thorium matrix: a potential source of auger therapy radionuclide (103m)rh
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741265/
https://www.ncbi.nlm.nih.gov/pubmed/29272318
http://dx.doi.org/10.1371/journal.pone.0190308
work_keys_str_mv AT mastrentara separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT radchenkovalery separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT hopkinsphilipd separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT englejonathanw separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT weidnerjohnw separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT coppingroy separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT brughmark separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT nortierfmeiring separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT birnbaumevar separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT johnkevind separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh
AT fassbendermichaelernstheinrich separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh